Magnetar Financial LLC Buys Shares of 26,510 Nu Skin Enterprises, Inc. (NYSE:NUS)

Magnetar Financial LLC purchased a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 26,510 shares of the company’s stock, valued at approximately $183,000. Magnetar Financial LLC owned 0.05% of Nu Skin Enterprises at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Ballentine Partners LLC lifted its stake in Nu Skin Enterprises by 15.5% during the fourth quarter. Ballentine Partners LLC now owns 20,856 shares of the company’s stock worth $144,000 after purchasing an additional 2,800 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Nu Skin Enterprises by 3.7% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 116,424 shares of the company’s stock worth $858,000 after buying an additional 4,125 shares during the last quarter. Inspire Investing LLC boosted its stake in Nu Skin Enterprises by 7.8% in the fourth quarter. Inspire Investing LLC now owns 65,418 shares of the company’s stock valued at $451,000 after buying an additional 4,728 shares in the last quarter. Catalyst Funds Management Pty Ltd grew its position in Nu Skin Enterprises by 15.3% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 39,100 shares of the company’s stock valued at $269,000 after acquiring an additional 5,200 shares during the last quarter. Finally, US Bancorp DE raised its stake in Nu Skin Enterprises by 424.2% during the fourth quarter. US Bancorp DE now owns 7,460 shares of the company’s stock worth $51,000 after acquiring an additional 6,037 shares in the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on NUS shares. DA Davidson reduced their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, December 20th. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th.

Read Our Latest Research Report on NUS

Nu Skin Enterprises Stock Performance

NYSE:NUS opened at $7.74 on Monday. The stock’s 50-day moving average is $7.34 and its 200-day moving average is $7.10. Nu Skin Enterprises, Inc. has a 1-year low of $5.95 and a 1-year high of $14.04. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56. The stock has a market cap of $384.61 million, a P/E ratio of -2.62 and a beta of 1.06.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last posted its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. The firm had revenue of $445.55 million for the quarter, compared to analyst estimates of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Equities research analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 3.10%. The ex-dividend date was Monday, February 24th. Nu Skin Enterprises’s dividend payout ratio is currently -8.14%.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Further Reading

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.